TY - JOUR
T1 - Spirometry measurement of peak inspiratory flow identifies suboptimal use of dry powder inhalers in ambulatory patients with COPD
AU - Duarte, Alexander G.
AU - Tung, Leon
AU - Zhang, Wei
AU - Hsu, En Shuo
AU - Kuo, Yong Fang
AU - Sharma, Gulshan
N1 - Publisher Copyright:
© 2019 COPD Foundation. All rights reserved.
PY - 2019
Y1 - 2019
N2 - Objectives: Determine the prevalence of suboptimal peak inspiratory flow rate (PIFR) and associated patient characteristics and compare PIFR measurements obtained with spirometry and In-Check DIAL® device in ambulatory patients with COPD. Methods: Patients underwent PIFR measurement with In-Check DIAL® device and pulmonary function testing with calibrated equipment. Group characteristics and lung function were compared for patients with suboptimal (≤ 60 L/min) and optimal (> 60 L/min) PIFR. Receiver operating curve analysis determined the best maximal forced inspiratory flow (FIF max) value in identifying optimal PIFR by gender and height. Results: From July 1, 2016 to January 31, 2018, a total of 303 patients with chronic obstructive pulmonary disease (COPD) had PIFR and pulmonary function measurements. Group mean age was 65.5 ± 11.3 years with equal gender distribution. Suboptimal PIFR was observed in 61 (20.1%) patients. A significant correlation was observed between PIFR and FIF max, inspiratory capacity and residual volume (RV) to total lung capacity (TLC) ratio. In the suboptimal PIFR group, mean FIF max measured by spirometry was significantly less compared with the optimal PIFR group; 178.5 ± 56.9 L/min and 263.4 ± 89.9 L/min, respectively (p<0.0001). Receiver operator curve analysis of FIF max to identify an optimal PIFR yielded an area under the curve of 0.79. Males < 65 inches had a suboptimal PIFR in 16.7 % of the Male cohort, while feMales < 65 inches had a suboptimal PIFR in 27.4% of the women. Conclusions: Suboptimal PIFR was present in 1 in 5 stable patients with COPD and was more frequent in short statured feMales. Spirometry determined FIF max was associated with PIFR based on gender and height.
AB - Objectives: Determine the prevalence of suboptimal peak inspiratory flow rate (PIFR) and associated patient characteristics and compare PIFR measurements obtained with spirometry and In-Check DIAL® device in ambulatory patients with COPD. Methods: Patients underwent PIFR measurement with In-Check DIAL® device and pulmonary function testing with calibrated equipment. Group characteristics and lung function were compared for patients with suboptimal (≤ 60 L/min) and optimal (> 60 L/min) PIFR. Receiver operating curve analysis determined the best maximal forced inspiratory flow (FIF max) value in identifying optimal PIFR by gender and height. Results: From July 1, 2016 to January 31, 2018, a total of 303 patients with chronic obstructive pulmonary disease (COPD) had PIFR and pulmonary function measurements. Group mean age was 65.5 ± 11.3 years with equal gender distribution. Suboptimal PIFR was observed in 61 (20.1%) patients. A significant correlation was observed between PIFR and FIF max, inspiratory capacity and residual volume (RV) to total lung capacity (TLC) ratio. In the suboptimal PIFR group, mean FIF max measured by spirometry was significantly less compared with the optimal PIFR group; 178.5 ± 56.9 L/min and 263.4 ± 89.9 L/min, respectively (p<0.0001). Receiver operator curve analysis of FIF max to identify an optimal PIFR yielded an area under the curve of 0.79. Males < 65 inches had a suboptimal PIFR in 16.7 % of the Male cohort, while feMales < 65 inches had a suboptimal PIFR in 27.4% of the women. Conclusions: Suboptimal PIFR was present in 1 in 5 stable patients with COPD and was more frequent in short statured feMales. Spirometry determined FIF max was associated with PIFR based on gender and height.
KW - COPD
KW - Chronic obstructive pulmonary disease
KW - Dry powder inhaler
KW - Inhalation therapy
KW - Peak inspiratory flow rate
KW - Pulmonary function test
UR - http://www.scopus.com/inward/record.url?scp=85073914079&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85073914079&partnerID=8YFLogxK
U2 - 10.15326/jcopdf.6.3.2018.0163
DO - 10.15326/jcopdf.6.3.2018.0163
M3 - Article
C2 - 31189057
AN - SCOPUS:85073914079
SN - 2372-952X
VL - 6
SP - 246
EP - 255
JO - Chronic Obstructive Pulmonary Diseases
JF - Chronic Obstructive Pulmonary Diseases
IS - 3
ER -